Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Shareholders' Equity

v3.25.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series B Conversion
Series C Conversion
Preferred Class B
Common Stock
Common Stock
Series B Conversion
Common Stock
Series C Conversion
Preferred Stock
Preferred Class B
Preferred Stock
Preferred Class B
Series B Conversion
Preferred Stock
Preferred Class B
Series C Conversion
Preferred Stock
Preferred Class C
Preferred Stock
Preferred Class C
Series C Conversion
Additional Paid-in Capital
Additional Paid-in Capital
Series B Conversion
Additional Paid-in Capital
Series C Conversion
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Noncontrolling Interest
Noncontrolling Interest
Series B Conversion
Common stock, Beginning balance (in shares) at Dec. 31, 2023         25,671,000                            
Beginning balance at Dec. 31, 2023 $ 764,261       $ 257     $ 0     $ 0   $ 283,684     $ 0 $ 480,320 $ 0  
Preferred stock, Beginning balance (in shares) at Dec. 31, 2023               0     0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net loss (88,794)                               (61,712) (27,082)  
Foreign currency translation adjustments (151)                             (151)      
Issuance of share-based awards (in shares)         100,000                            
Issuance of share-based awards 0       $ 1               (1)            
Payment of minimum tax withholdings on share-based awards (in shares)         (33,000)                            
Payment of minimum tax withholdings on share-based awards (1,326)                               (1,326)    
Share conversions   $ 0                                  
Shares issued - acquisition (in shares)         700,000     4,000     1,000                
Shares issued - acquisition 656,881       $ 7               223,425         433,449  
Share-based compensation expense 1,567                       1,567            
Repurchases and retirement of common stock 0                                    
Common stock, Ending balance (in shares) at Mar. 31, 2024         26,438,000                            
Preferred stock, Ending balance (in shares) at Mar. 31, 2024               4,000     1,000                
Ending balance at Mar. 31, 2024 1,332,438       $ 265     $ 0     $ 0   508,675     (151) 417,282 406,367  
Common stock, Beginning balance (in shares) at Dec. 31, 2023         25,671,000                            
Beginning balance at Dec. 31, 2023 764,261       $ 257     $ 0     $ 0   283,684     0 480,320 0  
Preferred stock, Beginning balance (in shares) at Dec. 31, 2023               0     0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net loss (1,060,141)                                    
Foreign currency translation adjustments (1,000)                                    
Common stock, Ending balance (in shares) at Jun. 30, 2024         27,699,000                            
Preferred stock, Ending balance (in shares) at Jun. 30, 2024               12,000     0                
Ending balance at Jun. 30, 2024 362,217       $ 277     $ 0     $ 0   512,638     (1,000) (228,151) 80,453  
Common stock, Beginning balance (in shares) at Mar. 31, 2024         26,438,000                            
Beginning balance at Mar. 31, 2024 1,332,438       $ 265     $ 0     $ 0   508,675     (151) 417,282 406,367  
Preferred stock, Beginning balance (in shares) at Mar. 31, 2024               4,000     1,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net loss (971,347)                               (645,433) (325,914)  
Foreign currency translation adjustments (849)                             (849)      
Issuance of share-based awards (in shares)         30,000                            
Share conversions (in shares)             1,210,000     8,000   (1,000)              
Share conversions     $ 0       $ 12               $ (12)        
Share-based compensation expense 3,620                       3,620            
Common stock issued under employee stock purchase plan (in shares)         21,000                            
Common stock issued under employee stock purchase plan 355                       355            
Common stock, Ending balance (in shares) at Jun. 30, 2024         27,699,000                            
Preferred stock, Ending balance (in shares) at Jun. 30, 2024               12,000     0                
Ending balance at Jun. 30, 2024 $ 362,217       $ 277     $ 0     $ 0   512,638     (1,000) (228,151) 80,453  
Common stock, Beginning balance (in shares) at Dec. 31, 2024 29,761,197       29,761,000                            
Beginning balance at Dec. 31, 2024 $ 285,868       $ 298     $ 0     $ 0   542,392     (2,732) (338,230) 84,140  
Preferred stock, Beginning balance (in shares) at Dec. 31, 2024 0     10,088       10,000     0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net loss $ (61,191)                               (50,637) (10,554)  
Foreign currency translation adjustments 265                             265      
Issuance of share-based awards (in shares)         97,000                            
Payment of minimum tax withholdings on share-based awards (in shares)         (30,000)                            
Payment of minimum tax withholdings on share-based awards (894)                               (894)    
Share conversions (in shares)           585,000     (1,000)                    
Share conversions   0       $ 6               $ 1,208         $ (1,214)
Share-based compensation expense 2,958                       2,958            
Common stock, Ending balance (in shares) at Mar. 31, 2025         30,413,000                            
Preferred stock, Ending balance (in shares) at Mar. 31, 2025               9,000     0                
Ending balance at Mar. 31, 2025 $ 227,006       $ 304     $ 0     $ 0   546,558     (2,467) (389,761) 72,372  
Common stock, Beginning balance (in shares) at Dec. 31, 2024 29,761,197       29,761,000                            
Beginning balance at Dec. 31, 2024 $ 285,868       $ 298     $ 0     $ 0   542,392     (2,732) (338,230) 84,140  
Preferred stock, Beginning balance (in shares) at Dec. 31, 2024 0     10,088       10,000     0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net loss $ (81,555)                                    
Foreign currency translation adjustments $ 4,826                                    
Common stock, Ending balance (in shares) at Jun. 30, 2025 30,606,895       30,607,000                            
Preferred stock, Ending balance (in shares) at Jun. 30, 2025 0     9,423       9,000     0                
Ending balance at Jun. 30, 2025 $ 216,241       $ 306     $ 0     $ 0   551,845     2,094 (402,451) 64,447  
Common stock, Beginning balance (in shares) at Mar. 31, 2025         30,413,000                            
Beginning balance at Mar. 31, 2025 227,006       $ 304     $ 0     $ 0   546,558     (2,467) (389,761) 72,372  
Preferred stock, Beginning balance (in shares) at Mar. 31, 2025               9,000     0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Net loss (20,364)                               (12,583) (7,781)  
Foreign currency translation adjustments 4,561                             4,561      
Issuance of share-based awards (in shares)         99,000                            
Payment of minimum tax withholdings on share-based awards (in shares)         (2,000)                            
Payment of minimum tax withholdings on share-based awards (107)                               (107)    
Share conversions (in shares)           80,000                          
Share conversions   $ 0       $ 1               $ 143         $ (144)
Share-based compensation expense 4,711                       4,711            
Common stock issued under employee stock purchase plan (in shares)         17,000                            
Common stock issued under employee stock purchase plan $ 434       $ 1               433            
Common stock, Ending balance (in shares) at Jun. 30, 2025 30,606,895       30,607,000                            
Preferred stock, Ending balance (in shares) at Jun. 30, 2025 0     9,423       9,000     0                
Ending balance at Jun. 30, 2025 $ 216,241       $ 306     $ 0     $ 0   $ 551,845     $ 2,094 $ (402,451) $ 64,447